|
|
||||||||
2-Microglobulin1From the Departments of Microbiology and Medicine, Case Western Reserve University and University Hospitals, Cleveland, Ohio 44106
Abstract
A human serum protein with structural homology to immunoglobulins,
2-microglobulin, was synthesized by normal lymphocytes in vitro. Production of microglobulin was increased when lymphocytes were stimulated with phytohemagglutinin (PHA) or concanavalin A (Con A) but was not increased by stimulation with pokeweed mitogen, suggesting that microglobulin was elaborated by thymus-dependent lymphocytes. Maximal
2-microglobulin production occurred at a concentration of PHA (2 µg/106 cells) which was far lower than that which led to maximal DNA and protein synthesis. Treatment of normal lymphocytes in culture with anti-
2-microglobulin and complement removed 20% of the cells and abolished
2-microglobulin production while stimulation of DNA synthesis by PHA was only slightly decreased. Fluorescein coupled antibody to
2-microglobulin stained virtually all normal lymphocytes, but 15 to 20% stained brightly. Although 15 to 25% of normal lymphocytes stained with anti-light chain antibody, none of these cells stained brightly with antibody to microglobulin when double-staining experiments were performed with two fluorochromes. Lymphocytes from a patient with acquired agammaglobulinemia synthesized microglobulin at a normal rate although the thymus independent (B) cell population as determined by staining for immunoglobulin was less than 3%. On the other hand, synthesis of microglobulin by lymphocytes from four patients with stage IV Hodgkin's disease was minimal. Production of
2-microglobulin by peripheral lymphocytes of patients with chronic lymphatic leukemia (CLL) was low when the lymphocytes were identified as B-cells; synthesis was normal, however, by lymphocytes lacking surface immunoglobulin in one case of CLL. These results suggest that in man
2-microglobulin is in large part the product of a thymic dependent lymphocyte subpopulation.
Footnotes
1 This work was supported by Research Grants AI10148 and AM14700 from the United States Public Health Service.
2 Recipient of Career Development Award 5-KO4-AI25732 from the Public Health Service.
3 Scholar of the Leukemia Society of America.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |